111 related articles for article (PubMed ID: 23217603)
1. Levamisole is an effective immunomodulator for patients with oral lichen planus.
Chiang CP
J Formos Med Assoc; 2012 Nov; 111(11):661. PubMed ID: 23217603
[No Abstract] [Full Text] [Related]
2. Levamisole can reduce the high serum tumour necrosis factor-alpha level to a normal level in patients with erosive oral lichen planus.
Sun A; Chia JS; Wang JT; Chiang CP
Clin Exp Dermatol; 2007 May; 32(3):308-10. PubMed ID: 17397355
[TBL] [Abstract][Full Text] [Related]
3. Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus.
Wu KM; Wang YP; Lin HP; Chen HM; Chia JS; Sun A
J Formos Med Assoc; 2013 Jun; 112(6):352-7. PubMed ID: 23602020
[TBL] [Abstract][Full Text] [Related]
4. Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus.
Lin HP; Wang YP; Chia JS; Sun A
J Formos Med Assoc; 2011 May; 110(5):316-21. PubMed ID: 21621152
[TBL] [Abstract][Full Text] [Related]
5. Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia.
Lu SY; Chang TF; Lin CJ
J Formos Med Assoc; 2019 Aug; 118(8):1193-1201. PubMed ID: 30922614
[TBL] [Abstract][Full Text] [Related]
6. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study.
Lu SY; Chen WJ; Eng HL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Oct; 86(4):438-45. PubMed ID: 9798228
[TBL] [Abstract][Full Text] [Related]
7. Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus.
Lin HP; Wang YP; Chia JS; Sun A
J Formos Med Assoc; 2011 Mar; 110(3):169-74. PubMed ID: 21497280
[TBL] [Abstract][Full Text] [Related]
8. Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus.
Sun A; Chiang CP
J Oral Pathol Med; 2001 Oct; 30(9):542-8. PubMed ID: 11555157
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.
Sun A; Chia JS; Chang YF; Chiang CP
J Oral Pathol Med; 2002 Apr; 31(4):196-203. PubMed ID: 12076322
[TBL] [Abstract][Full Text] [Related]
10. Sublingual surprise: a new variant of oral lichen planus.
Jin X; Hu T; Zhao X; Chen Q; Zeng X
Am J Med; 2014 Jan; 127(1):28-30. PubMed ID: 24384098
[No Abstract] [Full Text] [Related]
11. Modulation of serum gastric parietal cell antibody level by levamisole and vitamin B12 in oral lichen planus.
Lin HP; Wang YP; Chia JS; Chiang CP; Sun A
Oral Dis; 2011 Jan; 17(1):95-101. PubMed ID: 20659263
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus.
Sun A; Chiang CP; Chiou PS; Wang JT; Liu BY; Wu YC
J Oral Pathol Med; 1994 Apr; 23(4):172-7. PubMed ID: 7913970
[TBL] [Abstract][Full Text] [Related]
13. Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study.
Lu SY; Chen WJ; Eng HL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Dec; 80(6):705-9. PubMed ID: 8680979
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
Sun A; Wang JT; Chia JS; Chiang CP
Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of clinical data and immuno-modulating treatment of patients with oral lichen planus].
Kövesi G
Fogorv Sz; 2001 Feb; 94(1):9-14. PubMed ID: 11262802
[TBL] [Abstract][Full Text] [Related]
16. [Local immunomodulating agents in complex treatment of oral lichen planus].
Lukinykh LM; Tiunova NV
Stomatologiia (Mosk); 2013; 92(6):26-8. PubMed ID: 24429784
[TBL] [Abstract][Full Text] [Related]
17. [Modern approach to pathogenetic therapy of the oral mucosa lichen].
Ivanova EV; Shcherbakova EG; Rabinovich OF; Barsukov AA; Ezhova EG; Vasilenko IA
Stomatologiia (Mosk); 2005; 84(5):28-31. PubMed ID: 16247390
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of recurrence of herpetic keratitis by an immunomodulator : levamisole].
Vérin P
Bull Soc Ophtalmol Fr; 1981 Nov; 81(11):965-6. PubMed ID: 7340976
[No Abstract] [Full Text] [Related]
19. Levamisole in dermatology : a review.
Scheinfeld N; Rosenberg JD; Weinberg JM
Am J Clin Dermatol; 2004; 5(2):97-104. PubMed ID: 15109274
[TBL] [Abstract][Full Text] [Related]
20. [The combined treatment of lichen ruber planus of the mouth mucosa].
Volodina EV; Maksimovskiĭ IuM; Lebedev KA
Stomatologiia (Mosk); 1997; 76(2):28-32. PubMed ID: 9163080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
